The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein

Spike (S) protein is the primary antigenic target for neutralization and vaccine development for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It decorates the virus surface and undergoes large motions of its receptor binding domains (RBDs) to enter the host cell. Here, we observ...

Full description

Bibliographic Details
Main Authors: Hisham M Dokainish, Suyong Re, Takaharu Mori, Chigusa Kobayashi, Jaewoon Jung, Yuji Sugita
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2022-03-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/75720
_version_ 1797998540852559872
author Hisham M Dokainish
Suyong Re
Takaharu Mori
Chigusa Kobayashi
Jaewoon Jung
Yuji Sugita
author_facet Hisham M Dokainish
Suyong Re
Takaharu Mori
Chigusa Kobayashi
Jaewoon Jung
Yuji Sugita
author_sort Hisham M Dokainish
collection DOAJ
description Spike (S) protein is the primary antigenic target for neutralization and vaccine development for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It decorates the virus surface and undergoes large motions of its receptor binding domains (RBDs) to enter the host cell. Here, we observe Down, one-Up, one-Open, and two-Up-like structures in enhanced molecular dynamics simulations, and characterize the transition pathways via inter-domain interactions. Transient salt-bridges between RBDA and RBDC and the interaction with glycan at N343B support RBDA motions from Down to one-Up. Reduced interactions between RBDA and RBDB in one-Up induce RBDB motions toward two-Up. The simulations overall agree with cryo-electron microscopy structure distributions and FRET experiments and provide hidden functional structures, namely, intermediates along Down-to-one-Up transition with druggable cryptic pockets as well as one-Open with a maximum exposed RBD. The inherent flexibility of S-protein thus provides essential information for antiviral drug rational design or vaccine development.
first_indexed 2024-04-11T10:49:20Z
format Article
id doaj.art-e6d2fba80aa44428895594606307f61d
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-04-11T10:49:20Z
publishDate 2022-03-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-e6d2fba80aa44428895594606307f61d2022-12-22T04:28:57ZengeLife Sciences Publications LtdeLife2050-084X2022-03-011110.7554/eLife.75720The inherent flexibility of receptor binding domains in SARS-CoV-2 spike proteinHisham M Dokainish0https://orcid.org/0000-0002-4387-4790Suyong Re1https://orcid.org/0000-0002-3752-6554Takaharu Mori2https://orcid.org/0000-0002-8717-2926Chigusa Kobayashi3https://orcid.org/0000-0002-5603-4619Jaewoon Jung4https://orcid.org/0000-0002-2285-4432Yuji Sugita5https://orcid.org/0000-0001-9738-9216Theoretical Molecular Science Laboratory, RIKEN Cluster for Pioneering Research, Wako, JapanArtificial Intelligence Center for Health and Biomedical Research, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan; Laboratory for Biomolecular Function Simulation, RIKEN Center for Biosystems Dynamics Research, Kobe, JapanTheoretical Molecular Science Laboratory, RIKEN Cluster for Pioneering Research, Wako, JapanComputational Biophysics Research Team, RIKEN Center for Computational Science, Kobe, JapanTheoretical Molecular Science Laboratory, RIKEN Cluster for Pioneering Research, Wako, Japan; Computational Biophysics Research Team, RIKEN Center for Computational Science, Kobe, JapanTheoretical Molecular Science Laboratory, RIKEN Cluster for Pioneering Research, Wako, Japan; Laboratory for Biomolecular Function Simulation, RIKEN Center for Biosystems Dynamics Research, Kobe, Japan; Computational Biophysics Research Team, RIKEN Center for Computational Science, Kobe, JapanSpike (S) protein is the primary antigenic target for neutralization and vaccine development for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It decorates the virus surface and undergoes large motions of its receptor binding domains (RBDs) to enter the host cell. Here, we observe Down, one-Up, one-Open, and two-Up-like structures in enhanced molecular dynamics simulations, and characterize the transition pathways via inter-domain interactions. Transient salt-bridges between RBDA and RBDC and the interaction with glycan at N343B support RBDA motions from Down to one-Up. Reduced interactions between RBDA and RBDB in one-Up induce RBDB motions toward two-Up. The simulations overall agree with cryo-electron microscopy structure distributions and FRET experiments and provide hidden functional structures, namely, intermediates along Down-to-one-Up transition with druggable cryptic pockets as well as one-Open with a maximum exposed RBD. The inherent flexibility of S-protein thus provides essential information for antiviral drug rational design or vaccine development.https://elifesciences.org/articles/75720SARS-CoV-2spike proteinconformational transitioncryptic pocketsenhanced sampling
spellingShingle Hisham M Dokainish
Suyong Re
Takaharu Mori
Chigusa Kobayashi
Jaewoon Jung
Yuji Sugita
The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein
eLife
SARS-CoV-2
spike protein
conformational transition
cryptic pockets
enhanced sampling
title The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein
title_full The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein
title_fullStr The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein
title_full_unstemmed The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein
title_short The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein
title_sort inherent flexibility of receptor binding domains in sars cov 2 spike protein
topic SARS-CoV-2
spike protein
conformational transition
cryptic pockets
enhanced sampling
url https://elifesciences.org/articles/75720
work_keys_str_mv AT hishammdokainish theinherentflexibilityofreceptorbindingdomainsinsarscov2spikeprotein
AT suyongre theinherentflexibilityofreceptorbindingdomainsinsarscov2spikeprotein
AT takaharumori theinherentflexibilityofreceptorbindingdomainsinsarscov2spikeprotein
AT chigusakobayashi theinherentflexibilityofreceptorbindingdomainsinsarscov2spikeprotein
AT jaewoonjung theinherentflexibilityofreceptorbindingdomainsinsarscov2spikeprotein
AT yujisugita theinherentflexibilityofreceptorbindingdomainsinsarscov2spikeprotein
AT hishammdokainish inherentflexibilityofreceptorbindingdomainsinsarscov2spikeprotein
AT suyongre inherentflexibilityofreceptorbindingdomainsinsarscov2spikeprotein
AT takaharumori inherentflexibilityofreceptorbindingdomainsinsarscov2spikeprotein
AT chigusakobayashi inherentflexibilityofreceptorbindingdomainsinsarscov2spikeprotein
AT jaewoonjung inherentflexibilityofreceptorbindingdomainsinsarscov2spikeprotein
AT yujisugita inherentflexibilityofreceptorbindingdomainsinsarscov2spikeprotein